Risk-Based Screening Misses Many Breast Cancers
Mammography done on a risk-based approach among women in their forties misses a significant number of cancers, of which many are invasive.
A risk-based screening approach for breast cancer among women aged 40 to 49 would miss many cancers, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).
Researchers from the University of California, San Francisco (UCSF) undertook a retrospective study to determine the prevalence of a very strong family history and extremely dense breast tissue in women in this age group with breast cancer detected on screening mammography.
"Screening recommendations for this age group continue to be debated," researcher Bonnie N. Joe, MD, PhD, associate professor in residence and chief of women’s imaging, UCSF, said in a release. "Recent publications have suggested risk-based screening based on family history and breast density. However, our study shows that this approach would miss a significant percentage of invasive cancers and could potentially be dangerous."
The study included 136 women between the ages of 40 and 49 with breast cancer identified by screening mammography between 1997 and 2012. Patient family history, breast density, type of malignancy, lymph node status, and tumor receptor status were recorded.
The researchers found 194 cases of breast cancer identified by screening, 53% of which were invasive cancer and 47% were ductal carcinoma in situ. Of the patients with invasive disease, 23% had axillary nodal involvement. A very strong family history was absent in 90% and extremely dense breast tissue was absent in 86%. Seventy-eight percent of patients had neither strong family history nor extremely dense breasts, including 79% of the cases of invasive disease.
"Our results show that by exclusively using a risk-based approach to screening mammography, we could potentially miss more than 75 percent of breast cancers in women in their 40s, thereby eliminating most of the survival benefit from screening mammography that has been previously shown in randomized controlled trials," Joe noted in the release.
The researchers concluded that using a risk-based approach to screening mammography would reduce by more than 75% the number of screen-detected cancers.
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.
ECR Mammography Study: Pre-Op CEM Detects 34 Percent More Multifocal Masses than Mammography
February 28th 2025In addition to contrast-enhanced mammography (CEM) demonstrating over a 90 percent detection rate for multifocal masses, researchers found that no significant difference between histological measurements and CEM, according to study findings presented at the European Congress of Radiology.
Study: Mammography AI Leads to 29 Percent Increase in Breast Cancer Detection
February 5th 2025Use of the mammography AI software had a nearly equivalent false positive rate as unassisted radiologist interpretation and resulted in a 44 percent reduction in screen reading workload, according to findings from a randomized controlled trial involving over 105,000 women.
